Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.760
+0.040 (2.33%)
Jan 22, 2026, 4:00 PM EST - Market closed
Bone Biologics Market Cap
Bone Biologics has a market cap or net worth of $3.16 million as of January 23, 2026. Its market cap has increased by 11.53% in one year.
Market Cap
3.16M
Enterprise Value
-2.89M
1-Year Change
11.53%
Ranking
Category
Stock Price
$1.76
Market Cap Chart
Since March 31, 2016, Bone Biologics's market cap has decreased from $155.72M to $3.16M, a decrease of -97.97%. That is a compound annual growth rate of -32.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 3.16M | 21.38% |
| Dec 31, 2025 | 2.60M | 12.38% |
| Dec 31, 2024 | 2.32M | -4.06% |
| Dec 29, 2023 | 2.41M | -24.75% |
| Dec 30, 2022 | 3.21M | -91.19% |
| Dec 31, 2021 | 36.43M | -58.55% |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HCW Biologics | 3.65M |
| SciSparc | 3.60M |
| Ensysce Biosciences | 3.41M |
| Artelo Biosciences | 3.35M |
| GRI Bio | 3.24M |
| Azitra | 3.21M |
| Cardio Diagnostics Holdings | 3.20M |
| Scinai Immunotherapeutics | 3.00M |